Departamento de Ginecologia e Obstetrícia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.
Rev Bras Ginecol Obstet. 2022 Dec;44(12):1102-1109. doi: 10.1055/s-0042-1755462. Epub 2022 Aug 29.
To evaluate the use of misoprostol prior to hysteroscopy procedures regarding technical ease, the presence of side effects, and the occurrence of complications.
This is a retrospective, observational, analytical, case-control study, with the review of medical records of 266 patients followed-up at the Gynecological Videoendoscopy Sector of the Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto of the Universidade de São Paulo (HCFMRP - USP, in the Portuguese acronym) from 2014 to 2019, comparing 133 patients who used the drug before the procedure with 133 patients who did not.
The occurrence of postmenopausal uterine bleeding was the main indication for hysteroscopy and revealed a statistical difference between groups ( < 0.001), being present in 93.23% of the patients in the study group and in 69.7% of the patients in the control group.: Only 2 patients (1.5%) in the study group reported adverse effects. Although no statistical differences were observed regarding the occurrence of complications during the procedure ( = 0.0662), a higher total number of complications was noted in the group that used misoprostol ( = 7; 5.26%) compared with the group that did not use the drug ( = 1; 0.75%), a fact that is clinically relevant. When evaluating the ease of the technique (measured by the complete performance of all steps of the hysteroscopy procedure), it was verified that although there was no difference between groups ( = 0.0586), the control group had more than twice as many incompletely performed procedures ( = 17) when compared with the group that used misoprostol previously ( = 8), which is also clinically relevant.
The use of misoprostol prior to hysteroscopy in our service indicated that the drug can facilitate the performance of the procedure, but not without side effects and presenting higher complication rates.
评估在宫腔镜检查前使用米索前列醇对技术难度、副作用的发生以及并发症的发生的影响。
这是一项回顾性、观察性、分析性病例对照研究,对 2014 年至 2019 年在圣保罗大学里贝朗普雷托医学院附属医院妇科内镜科接受治疗的 266 名患者的病历进行了回顾,将 133 名在检查前使用该药物的患者与 133 名未使用该药物的患者进行了比较。
绝经后子宫出血是进行宫腔镜检查的主要指征,且组间存在统计学差异( < 0.001),研究组中有 93.23%的患者存在该症状,而对照组中则有 69.7%的患者存在该症状。仅 2 名(1.5%)研究组患者报告出现不良反应。尽管在手术过程中发生并发症的发生率方面未观察到统计学差异( = 0.0662),但使用米索前列醇的组( = 7;5.26%)的总并发症数量高于未使用药物的组( = 1;0.75%),这在临床上是相关的。当评估技术的难易程度(通过宫腔镜检查程序的所有步骤的完全执行情况来衡量)时,虽然组间无差异( = 0.0586),但与使用米索前列醇的组( = 8)相比,未使用药物的组( = 17)有更多未完全执行的程序,这在临床上也是相关的。
在我们的服务中,在宫腔镜检查前使用米索前列醇表明该药物可以促进手术的进行,但并非没有副作用,且并发症发生率更高。